COVID-19 vaccination in Germany

Last updated

COVID-19 vaccination in Germany
COVID19-Impfungen 1. Dezember 2021.jpg
Map of COVID19 vaccinations in Germany by federal states (as of December 1, 2021). For more recent data visit the webpage of the RKI. [1]
Date26 December 2020 (2020-12-26) – present
LocationGermany
Cause COVID-19 pandemic in Germany
TargetFull immunisation of people in Germany against COVID-19
Participants55,869,314 people with one dose
52,503,166 people fully vaccinated (19 September 2021)
Website Official Website

The COVID-19 vaccination campaign in Germany began on 26 December 2020. [2]

Contents

As of 16 December 2021, 60,679,186 people have received at least one dose (73% of total population), while 58,174,724 people have been fully vaccinated (70% of total population). [3] And as of 8 April 2023, 63.6 million people (76.4% of the total population) received the Grundimmunisierung (two doses or one dose and undergone infection) while 52.1 million people (62.6%) had received at least one additional booster dose. [4]

In January 2023, the health ministry stated that the expenditure on vaccines to date was 13.1 billion euros. [5]

Vaccines on order

German vaccination certificate with evidence of two-dose of COVID-19 vaccination Impfpass mit COVID 19 Impfungen.jpg
German vaccination certificate with evidence of two-dose of COVID-19 vaccination

There are several COVID-19 vaccines at various stages of development around the world. The ones listed as "pending" in the column "approval" in the table below were under review by the European Medicines Agency as of 15 May 2021, [6] with unclear status as of July 2023.

VaccineApprovalDeployment
Pfizer–BioNTech Green check.svg 21 December 2020Green check.svg 26 December 2020
Moderna Green check.svg 6 January 2021Green check.svg 12 January 2021
Oxford–AstraZeneca Green check.svg 29 January 2021Green check.svg 7 February 2021
Janssen Green check.svg 11 March 2021Green check.svg 5 May 2021
Novavax Green check.svg 20 December 2021Green check.svg 21 March 2022 [7]
VLA2001 Green check.svg 24 June 2022Green check.svg 9 September 2022 [8]
VidPrevtyn BetaGreen check.svg 10 November 2022Green check.svg 12 December 2022 [9]
Bimervax (COVID-19 Vaccine HIPRA)Green check.svg 30 March 2023 [10] Pending
CoronaVac PendingNo
but recognition on 31 March 2022 [11]
Sputnik V Pending (but suspended since March 2022) [12] No
but recognition on 31 March 2022 [11]
CureVac Cancelled process mini.svg Request withdrawnNo

The German Immunization Committee (STIKO) initially recommended jabs from AstraZeneca [13] and Janssen only for patients ages 60 and above after reports of blood clot post-vaccination, but this was made available to everyone by the federal government on 6 May 2021 [14] and 10 May 2021, [15] respectively. On November 10 of the same year, STIKO recommended jabs from Moderna's vaccine mRNA-1273 only to persons 30 years of age and older due to the increased risk of myocarditis and pericarditis for young people, and the vaccine from Biontech/Pfizer was the only recommended vaccine for young people. [16]

Doses delivered (cumulative)

As of 19 July 2021

Timeline of vaccination

COVID-19 vaccination center in Hall 4 of Cologne Trade Fair. COVID-19 vaccination center, fair grounds Cologne-6467.jpg
COVID-19 vaccination center in Hall 4 of Cologne Trade Fair.

Priority groups

At the beginning of the vaccination campaign, the vaccine was planned to be distributed in four priority groups. [17]

Vaccination group 1

The first priority group received their first vaccination on 26 December 2020. Everyone ages 80 and above, residents & caretakers of senior residents and high risk medical personnel are included in this group.[ citation needed ]

Vaccination group 2

This group consists of everyone ages 70 to 79, people with high risk preexisting conditions or Down's Syndrome or psychologically impaired and their caretakers, caretakers of pregnant women, and other medical personnel not included in group 1.

Vaccination group 3

Group 3 consists of everyone ages 60 to 69, people with moderate preexisting conditions and their caretakers, employees of the government, shops, and vital infrastructure, and teachers.

Vaccination group 4

Everyone under the age of 60, but at least 16 years old, who are not included in the above vaccination group will be the last to get inoculation once most members of the top three priority groups receive their first dose. At a press conference on 26 April 2021, chancellor Angela Merkel promised to remove the prioritization by June, [18] with Health Minister Jens Spahn later announcing its end on June 7, 2021. [19] However, the states of Baden-Württemberg, Bavaria, and Berlin decided to enable this group to also get vaccinated through a doctor's office starting on 17 May 2021. [20] [21] [22]

On 27 May 2021, chancellor Angela Merkel announced the extension of this priority to include children ages 12 to 15, on the condition that at least one existing vaccine is approved for use in this age range by the European Medicines Agency (EMA). [23]

Slowing of vaccination campaign and government response

On 8 August 2021, it was reported that in response to a decreasing demand for vaccinations, in particular the Oxford–AstraZeneca COVID-19 vaccine, the Health Ministry would, starting from 16 August, distribute vaccines to the 16 states on the basis of reported demand, instead of the maximum feasible amounts. For the same reason, states projected in a survey by Die Welt that they would return over 2 million vaccine doses to the federal government. Development minister Gerd Müller told the newspaper that the amount of 30 million vaccine doses already promised should be increased in view of the situation, and that as the next step, the capacities for domestic production in poorer countries should be improved. [24]

From 13 to 19 September, mobile vaccination centers were set up on public transport, mosques, and football fields as part of a campaign to increase the vaccination rate in the population. [25]

Initiatives for vaccine mandates

Since October 2021, there was increased support for the introduction of mandates for vaccination against Covid-19 and the newly formed Scholz cabinet endorsed the initiatives with some reservations on the part of the coalition partner FDP. The vaccine mandate for employees in clinics and nursing homes (einrichtungsbezogene Impfpflicht) passed the Bundestag on 10 December 2021 and became law. [26]

But none of the legislative proposals for a general vaccine mandate received a majority in the vote in the Bundestag on 7 April 2022, [27] and the German government decided not to pursue initiatives for a general mandate any further. [28]

Finally, the vaccine mandate for employees in clinics and nursing homes (einrichtungsbezogene Impfpflicht) ceased with the end of 2022. [29]

Incidents

In August 2021, authorities in north Germany found that a nurse injected saline instead of vaccine, and had to ask more than 8,000 people to get repeat Covid vaccinations. [30]

Statistics

Vaccination figures were obtained from the RKI, updated every business day and correspond to progress on the previous day. [31] Starting from April, inoculations can also be administered at a doctor's office alongside the existing vaccination center and mobile teams [32] and from 7 June at a company's physician office. A first dose is described as a person who received at least one COVID-19 vaccine doses, while a full dose stands for a person who completed the vaccination process with the prescribed doses.

Cumulative vaccinations

Vaccinations per day

Vaccination by federal state

First and second vaccination by federal state
Federal stateVaccinated populationPercentage of population vaccinated
first dosefull dosebooster dosefirst dosefull dosebooster dose
Flag of Baden-Wurttemberg.svg Baden-Württemberg 7,573,6737,374,131924,13768.2%66.4%8.3%
Flag of Bavaria (lozengy).svg Bavaria 9,002,2878,735,4311,335,73368.5%66.5%10.2%
Flag of Berlin.svg Berlin 2,620,2482,526.217461,18371.5%68.9%12.6%
Flag of Brandenburg.svg Brandenburg 1,626,0731,567,530206,97264.2%61.9%8.2%
Flag of Bremen.svg Bremen 4,456,3664,241,163531,82570.8%67.4%8.5%
Flag of Hamburg.svg Hamburg 1,410,0151,371,397164,66476.1%74.0%8.9%
Flag of Hesse.svg Hesse 4,456,3664,241,163531,82570.8%67.4%8.5%
Flag of Mecklenburg-Western Pomerania.svg Mecklenburg-Vorpommern 1,110,8931,074,521146,09569.0%66.7%9.1%
Flag of Lower Saxony.svg Lower Saxony 5,856,5855,613,878748,55073.2%70.1%9.4%
Flag of North Rhine-Westphalia.svg North Rhine-Westphalia 13,447,37412,838,4481,850,98375.0%71.6%10.3%
Flag of Rhineland-Palatinate.svg Rhineland-Palatinate 2,957,2662.786,767374,72372.2%68.0%9.1%
Flag of Saarland.svg Saarland 760,872735,825109,99477.3%74.8%11.2%
Flag of Saxony.svg Saxony 2,445,5702,351,886303,95860.3%58.0%7.5%
Flag of Saxony-Anhalt.svg Saxony-Anhalt 1,450,0621,412,577194,68766.5%64.8%8.9%
Flag of Schleswig-Holstein.svg Schleswig-Holstein 2,187,7552,113,758306,80075.2%72.6%10.5%
Flag of Thuringia.svg Thuringia 1,356,5451,320,893230,96464.0%62.3%10.9%
Bundeswehr Kreuz Black.svg Bundespolizei-Logos.svg Bundeswehr / German Federal Police 194,512186,91410,143–––
Flag of Germany.svg Germany 59,018,26356,795,1427,981,43571.0 %68.3 %9.6 %
Total injected doses120,376,028
As of 26 November 2021 per data from Robert Koch Institut.

Post-vac reports in Germany

The term post-vac (or post-vac syndrome, post-vaccine syndrome, post-vax) is used in Germany, Switzerland [33] and Austria [34] in connection with long-standing symptoms somewhat similar to long covid symptoms and does not indicate a defined disease or designation. No causal relationship has been found between the corona vaccination against COVID-19 and symptoms attributed to post-vac, such as chronic fatigue syndrome, orthostatic hypotension and Long covid-like symptoms, however post-vac has been little studied. [35] It was suggested that the term post-vac syndrome should not be used as it is imprecise; instead, the term post-COVID-19 vaccination syndrome, PCVS, colloquially post-COVIDvac-syndrome, should be used and a distinction made between acute COVID-19 vaccination syndrome (ACVS) and post-acute COVID-19 vaccination syndrome (PACVS) – in analogy to acute COVID-19 and post-acute COVID-19 syndrome (PACS, long COVID). [36]

In Germany, the University Hospital of Giessen and Marburg (Universitätsklinikum Giessen und Marburg - UKGM) has established a treatment and research center for post-vac syndrome. [37] [38] [39]

Assessment by the Paul Ehrlich Institute

The German Paul Ehrlich Institute (PEI) publishes a safety reports on reports of suspected corona vaccine adverse reactions and complications related to the approved COVID-19 vaccines, and the PEI reviews these reports. In the 7 September 2022 safety notice, which covers a time period from 27 December 2020 to 30 June 2022, the PEI refers for the first time to the concept of post-vac syndrome and examines reports of long-standing complaints after vaccination. [40] It was found that chronic fatigue, postural orthostatic tachycardia syndrome and pulmonary Covid-like complaints after vaccination were no more common than would be expected based on normal incidence.

The follow-up statement from May 2023 on "post-vac" (data till mid-May 2023) [41] and the comprehensive safety report (data till end of March 2023) from June 2023 from the Paul Ehrlich Institut (PEI) confirmed that more than half of the reported cases worldwide (1452 out of 2657 as of 31 March 2023) of "Post-Vac" have been reported from Germany. [42] [43] [44]

Reaction by the German health authorities

The German Federal Minister for Health, Karl Lauterbach, mentioned in a ZDF TV-interview on 12 March 2023 the occurrence of corona-vaccination damages and the post-vac syndrome. Lauterbach indicated that there was yet no drug available, nor a treatment method. He promised financial help for the victims. [45]

Since the end of March 2023 the Bavarian ministry of health established a telephone hotline for people suspecting a "Post-Vac-Syndrom". [46]

Related Research Articles

<span class="mw-page-title-main">Sinovac Biotech</span> Chinese biopharmaceutical company

Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China.

<span class="mw-page-title-main">COVID-19 pandemic in Germany</span> Ongoing COVID-19 viral pandemic in Germany

The COVID-19 pandemic in Germany has resulted in 38,437,756 confirmed cases of COVID-19 and 174,979 deaths.

<span class="mw-page-title-main">Vaccine diplomacy</span> Use of vaccines as international diplomacy

Vaccine diplomacy, a form of medical diplomacy, is the use of vaccines to improve a country's diplomatic relationship and influence of other countries. Meanwhile, vaccine diplomacy also "means a set of diplomatic measures taken to ensure access to the best practices in the development of potential vaccines, to enhance bilateral and/or multilateral cooperation between countries in conducting joint R&D, and, in the case of the announcement of production, to ensure the signing of a contract for the purchase of the vaccine at the shortest term." Although primary discussed in the context of the supply of COVID-19 vaccines, it also played a part in the distribution of the smallpox vaccine.

<span class="mw-page-title-main">CoronaVac</span> Vaccine against COVID-19

CoronaVac, also known as the Sinovac COVID-19 vaccine, is a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was phase III clinically trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen, and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), the temperatures at which flu vaccines are kept.

<span class="mw-page-title-main">COVID-19 vaccination in Switzerland</span> Plan to immunize against COVID-19

COVID-19 vaccination in Switzerland is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">EpiVacCorona</span> EpiVacCorona vaccine against COVID-19

EpiVacCorona is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack of protective effectiveness of EpiVacCorona, which is still in use in Russia, has been reported in scientific literature and in the media. The vaccine consists of three chemically synthesized peptides that are conjugated to a large carrier protein. This protein is a fusion product of a viral nucleocapsid protein and a bacterial MBP protein. A phase III clinical trial to show whether or not the vaccine can protect people against COVID-19 was launched in November 2020 with more than three thousand participants. The conclusions and results of the trial have not been made public.

<span class="mw-page-title-main">COVID-19 vaccination in Albania</span>

The COVID-19 vaccination campaign in Albania is a mass immunization campaign that was put in place by the Albanian authorities in order to respond to the ongoing COVID-19 pandemic. It started on 11 January 2021.

<span class="mw-page-title-main">COVID-19 vaccination in South Africa</span> Plan to immunize against COVID-19 in South Africa

COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in Africa</span> Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs are ongoing in the majority countries and territories in Africa, with 51 of 54 African countries having launched vaccination programs by July 2021. As of October 2023, 51.8% of the continent's population is fully vaccinated with over 1084.5 million doses administered.

<span class="mw-page-title-main">COVID-19 vaccination in Mexico</span> Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in Indonesia</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks third in Asia and fifth in the world.

<span class="mw-page-title-main">COVID-19 vaccination in Singapore</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population having completed their vaccination regimen.

<span class="mw-page-title-main">COVID-19 vaccination in Brazil</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Brazil is an ongoing mass immunization campaign for the COVID-19 pandemic in Brazil. It started on January 17, 2021, when the country had 210 thousand deaths.

<span class="mw-page-title-main">COVID-19 vaccination in Ukraine</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.

<span class="mw-page-title-main">German government response to the COVID-19 pandemic</span> Actions by the German government on COVID-19 pandemic

The government of Germany has initially responded to the COVID-19 pandemic in the country with preventive measures to curb the spread of the coronavirus disease 2019 in the country. With the nationwide spread of the disease from March 2020, preventive measures were replaced by containment measures, including a lockdown from March. On 25 March, the Bundestag made the determination of an epidemic situation of national significance. This created a legal framework for the government of chancellor Angela Merkel and the heads of the 16 German states to agree on nationwide pandemic restrictions. Implementation of decisions by that panel remained a matter of individual states, however, leading to differences in anti-pandemic rules and regulations across states.

The 2022–2023 mpox outbreak in Germany is part of an ongoing global outbreak of human mpox caused by the West African clade of the monkeypox virus. At the beginning of September 2022, Spain, France, Germany and the United Kingdom are the countries with most cumulative cases in Europe.

Thomas Michael Christian Mertens is a German virologist who currently heads the Standing Committee on Vaccination (STIKO), which as part of the Robert Koch Institute advises the German government regarding vaccines.

References

  1. ↑ "Digitales Impfquotenmonitoring zur COVID-19-Impfung" [Digital vaccination rate monitoring for COVID-19 vaccination]. www.rki.de (in German). Retrieved 23 July 2023.
  2. ↑ "Erste Corona-Impfungen in Halberstadt: Pieks für 101-Jährige" (in German). dpa. 26 December 2020. Retrieved 11 May 2021.
  3. ↑ "Aktueller Impfstatus". impfdashboard.de (in German). Federal Ministry of Health (Germany). Archived from the original on 14 January 2021. Retrieved 16 December 2021.
  4. ↑ "COVID-19-Impfung in Deutschland bis zum 8. April 2023: Übersicht zum Impfstatus" . Retrieved 9 July 2023.
  5. ↑ "Bund bestellte Coronaimpfstoffe für mehr als 13 Milliarden Euro". Deutsches Ärzteblatt (in German). 26 January 2023. Retrieved 26 January 2023.
  6. ↑ "COVID-19 vaccines: under evaluation". European Medicines Agency. n.d. Retrieved 15 May 2021.
  7. ↑ Praxen erhalten ab 21. März Impfstoff von Novavax - Bestellsituation weiterhin entspannt (www.kbv.de, 10 March 2022)
  8. ↑ Neue Impfstoffvarianten im Landkreis verfügbar
  9. ↑ Proteinbasierter Booster-Impfstoff von Sanofi jetzt bestellbar (www.kbv.de, 30 November 2022)
  10. ↑ COVID-19-Impfstoff Bimervax für Auffrischimpfungen zugelassen
  11. 1 2 recognized as proven efficient ("Inzwischen liegen jedoch Daten vor, die zeigen...", CoronaVac) resp. expected to be efficient ("In Analogie ... ist jedoch davon auszugehen...", Sputnik V) by the Standing Committee on Vaccination (STIKO), see page 3 (Beschluss der STIKO zur 19. Aktualisierung der COVID-19-Impfempfehlung) of Epidemiologisches Bulletin 13/2022 (www.rki.de, 31 March 2022)
  12. ↑ Prüfung von russischem Coronaimpfstoff in der EU ausgesetzt (www.spiegel.de, 18 March 2022)
  13. ↑ "Germany restricts use of AstraZeneca vaccine to over 60s in most cases". Deutsche Welle. 30 March 2021. Retrieved 11 May 2021.
  14. ↑ "Coronavirus: Germany opens up AstraZeneca COVID vaccines for all adults". Deutsche Welle. 6 May 2021. Retrieved 11 May 2021.
  15. ↑ "Johnson & Johnson prioritization lifted" (in German). tagesschau. Retrieved 2 June 2021.
  16. ↑ Alkousaa, Riham (10 November 2021). "Germany recommends only Biontech/Pfizer vaccine for under-30s". Reuters . Archived from the original on 10 November 2021. Retrieved 21 December 2021.
  17. ↑ "Vaccination priority" (PDF). German Ministry of Health. Retrieved 10 May 2021.
  18. ↑ "Merkel: Germany to let everyone apply for vaccine by June". Deutsche Welle. 26 April 2021. Retrieved 12 May 2021.
  19. ↑ "Germany to open up vaccines to all adults from June 7th: What you need to know". thelocal.de. 18 May 2021. Retrieved 2 June 2021.
  20. ↑ "Coronavirus in Bavaria: Assistance in English". Bayerischer Rundfunk. Retrieved 12 May 2021.
  21. ↑ "Corona-Impfungen in Arztpraxen künftig freigegeben - große Nachfrage". Südwestrundfunk. 12 May 2021. Archived from the original on 11 May 2021. Retrieved 12 May 2021.
  22. ↑ "Ab Montag Berlin hebt Impfpriorisierung bei Ärzten auf" (in German). Rundfunk Berlin-Brandenburg. 13 May 2021. Retrieved 13 May 2021.
  23. ↑ Thurau, Jens (27 May 2021). "COVID: Germany's Merkel wants vaccines for children aged 12 to 15". Deutsche Welle. Retrieved 2 June 2021.
  24. ↑ Doll, Nikolaus (8 August 2021). "Bundesländer geben mehr als zwei Millionen Impfdosen zurück". Die Welt (in German). Retrieved 12 August 2021.
  25. ↑ "German Chancellor Angela Merkel kicks off COVID vaccination action week". Deutsche Welle. 12 September 2021. Retrieved 16 September 2021.
  26. ↑ "Impfpflicht für Beschäftigte in Kliniken und Heimen beschlossen" [Compulsory vaccination for employees in clinics and homes passed]. www.bundesregierung.de (in German). 10 December 2021. Retrieved 9 July 2023.
  27. ↑ "Initiativen zur Corona-Impfpflicht fallen im Bundestag durch" [Initiatives for compulsory Corona vaccination fail to pass in the Bundestag]. www.bundestag.de (in German). Retrieved 9 July 2023.
  28. ↑ "German government drops plan for Covid vaccine mandate". www.theguardian.com. 8 April 2022. Retrieved 9 July 2023.
  29. ↑ "Corona-Impfpflicht im Gesundheitswesen läuft Ende des Jahres aus" [Corona vaccination requirement in health care expires at the end of the year] (in German). www.rbb24.de. 22 November 2022. Retrieved 9 July 2023.
  30. ↑ "Covid: Germany fears thousands got saline, not vaccine from nurse". BBC News. 12 August 2021.
  31. ↑ "RKI - Coronavirus SARS-CoV-2 - Digitales Impfquotenmonitoring zur COVID-19-Impfung".
  32. ↑ "Germany: Merkel, state leaders agree on strategy to jump-start vaccinations". Deutsche Welle. 19 March 2021. Retrieved 16 April 2021.
  33. ↑ "Post-Vac-Syndrom - Schwer krank nach Covid-Impfung: Seltenheit oder Leid mit System?". www.srf.ch. 10 February 2023. Retrieved 15 July 2023.
  34. ↑ "Covid-Impfschäden und "Post Vac": Wie sieht eine erste Bilanz aus?". www.sn.at. 2 May 2023. Retrieved 15 July 2023.
  35. ↑ "Wie verbreitet ist das Post-Vac-Syndrom?" [How common is Post-Vac Syndrome?]. 3 July 2023. Retrieved 13 July 2023.
  36. ↑ Scholkmann, Felix; May, Christian-Albrecht (June 2023). "COVID-19, post-acute COVID-19 syndrome (PACS, "long COVID") and post-COVID-19 vaccination syndrome (PCVS, "post-COVIDvac-syndrome"): Similarities and differences". Pathology - Research and Practice. 246: 154497. doi:10.1016/j.prp.2023.154497. PMC   10154064 . PMID   37192595.
  37. ↑ "Spezialsprechstunde Post-Vax" [Post-Vac Special Consultation]. www.ukgm.de. Retrieved 13 July 2023.
  38. ↑ "Post-vac syndrome — the forgotten COVID victims". www.dw.com/en. 21 March 2023. Retrieved 13 July 2023.
  39. ↑ "Treating the Post-Vac-Syndrome". www.dw.com. 11 October 2022.
  40. ↑ The Paul-Ehrlich Institute's Safety Notice from 14 September 2022. "Bericht über Verdachtsfälle von Nebenwirkungen und Impfkomplikationen nach Impfung zum Schutz vor COVID-19 (Berichtszeitraum 27.12.2020 bis 30.06.2022)" (PDF). Retrieved 13 July 2023.
  41. ↑ "Statement from the Paul-Ehrlich-Institut on "Post-Vac Syndrome" after COVID-19 Vaccination (dated 19 May 2023)" (PDF). www.pei.de. Retrieved 16 July 2023. When comparing the absolute numbers of reports of suspected cases presented, it seems notable that at the time of the evaluation, more than 50% of all suspected cases registered worldwide (n=2,817) with these symptoms were reported from Germany (n= 1,547).
  42. ↑ "Experts rätseln: Long-Covid-Symptome nach Impfung? Hälfte aller Verdachtsfälle aus Deutschland gemeldet]" [Experts puzzled: Long Covid symptoms after vaccination? Half of all suspected cases reported from Germany]. www.focus.de. 7 July 2023. Retrieved 13 July 2023.
  43. ↑ ""Post-Vac-Syndrom": Mehr als die Hälfte der weltweiten Fälle in Deutschland registriert". www.aerzteblatt.de (in German). 29 June 2023. Retrieved 13 July 2023.
  44. ↑ "Sicherheitsprofil der COVID-19-Impfstoffe – Sachstand 31.03.2023" [Safety profile of COVID-19 vaccines - state of affairs 03/31/2023](PDF). www.pei.de (in German). Retrieved 9 July 2023.
  45. ↑ "Post-Vac und Long Covid : Lauterbach verspricht Hilfe nach Impfschäden". www.zdf.de. 12 March 2023. Retrieved 13 July 2023.
  46. ↑ "PRESSEMITTEILUNG Nr.96/GP". www.stmgp.bayern.de. 31 March 2023. Retrieved 15 July 2023.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.